CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 119 filers reported holding CARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -14.8% | 1,440 | -1.7% | 0.01% | -16.7% |
| Q3 2019 | $27,000 | -12.9% | 1,465 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $31,000 | +6.9% | 1,465 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $29,000 | +52.6% | 1,465 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $19,000 | -45.7% | 1,465 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $35,000 | +25.0% | 1,465 | 0.0% | 0.01% | +27.3% |
| Q2 2018 | $28,000 | +55.6% | 1,465 | +1.7% | 0.01% | +37.5% |
| Q1 2018 | $18,000 | 0.0% | 1,440 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $18,000 | -10.0% | 1,440 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $20,000 | -9.1% | 1,440 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $22,000 | -15.4% | 1,440 | 0.0% | 0.01% | -25.0% |
| Q1 2017 | $26,000 | +100.0% | 1,440 | 0.0% | 0.01% | +71.4% |
| Q4 2016 | $13,000 | +8.3% | 1,440 | 0.0% | 0.01% | +16.7% |
| Q3 2016 | $12,000 | – | 1,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
| Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
| Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
| DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
| Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
| DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
| B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |